Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» With an FDA decision looming, Flexion touts new data spotlighting a safety edge for osteoarthritis drug
With an FDA decision looming, Flexion touts new data spotlighting a safety edge for osteoarthritis drug
With an FDA decision looming, Flexion touts new data spotlighting a safety edge for osteoarthritis drug
Submitted by
admin
on June 12, 2017 - 9:49am
Source:
Endpoints
News Tags:
FDA
Flexion
Zilretta
osteoarthritis
Headline:
With an FDA decision looming, Flexion touts new data spotlighting a safety edge for osteoarthritis drug
Do Not Allow Advertisers to Use My Personal information
